Amuge, PaulineLugemwa, AbbasMujuru, Hilda A.Kityo, Cissy M.Atwine, LornaFord, Deborah2025-02-192025-02-192022-09-17Amuge, P., Lugemwa, A., Wynne, B., Mujuru, H. A., Violari, A., Kityo, C. M., ... & Goodman, A. (2022). Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial. The Lancet HIV, 9(9), e638-e648.fhttps://nru.uncst.go.ug/handle/123456789/9970Young children living with HIV have few treatment options. We aimed to assess the efficacy and safety of dolutegravir-based antiretroviral therapy (ART) in children weighing between 3 kg and less than 14 kg.enArticle